Walgreens Boots Alliance
RANK
27
The pharmacy and health care provider dropped nine spots on the list this year, as demand for services related to COVID—including vaccines, testing, and treatment—dropped sharply. But profits rose by 70%, to $4.3 billion, in the company’s second full year under CEO Rosalind “Roz” Brewer.
- In its continuing efforts to expand into health care services, Walgreens announced in October 2022 that it would acquire in full home-health-care company CareCentrix, purchasing the remaining 45% stake.
- Like other health care companies, Walgreens has faced intense scrutiny for its alleged role in the opioid crisis. Under a settlement announced in December 2022, Walgreens will pay state and local governments up to $5.5 billion over 15 years to resolve lawsuits that accused its pharmacies of overprescribing opioids. (The company did not admit wrongdoing.)
- In March 2023, Walgreens announced that it would not fill prescriptions for mifepristone, a drug commonly used in medical abortions, in states where lawmakers were threatening legal action against use of the drug. That decision drew angry responses from pro-choice lawmakers and activists.
Jeffrey Greenberg—UCG/Universal Images Group/Getty Images
Company Information
As of 6/5/23
Country
U.S.
Headquarters
Deerfield, Ill.
Industry
Food and Drug Stores
CEO
Roz Brewer
Company Type
Public
Ticker
WBA
Revenues ($M)
$132,703
Profits ($M)
$4,337
Market Value ($M)
$29,836
Employees
262,500
Figures are for fiscal year ended Aug. 31, 2022. Market value as of March 31, 2023.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$132,703
-10.7%
Profits ($M)
$4,337
70.6%
Assets ($M)
$90,124
-
Total Stockholder Equity ($M)
$25,275
-
Profit Ratios
Profit as % of Revenues
3.3%
Profits as % of Assets
4.8%
Profits as % of Stockholder Equity
17.2%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
5.01
EPS % Change (from 2021)
71%
EPS % Change (5 year annual rate)
5.8%
EPS % Change (10 year annual rate)
7.5%
Total Return
Total Return to Investors (2022)
-25%
Total Return to Investors (5 year, annualized)
-9.2%
Total Return to Investors (10 year, annualized)
2.9%
Walgreens Boots Alliance Rank History
Historical Data
| Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
|---|---|---|---|---|
| 2022 | $148,5796.5% | $2,542457.5% | $81,285 | $23,419 |
| 2021 | $139,5372% | $456-88.5% | $87,174 | $20,637 |
| 2020 | $136,8664.1% | $3,982-20.7% | $67,598 | $23,512 |
| 2019 | $131,53711.3% | $5,02423.2% | $68,124 | $26,007 |
| 2018 | $118,2140.7% | $4,078-2.3% | $66,009 | $27,466 |
SHOW MORE
Lists ranking Walgreens Boots Alliance
Latest news for Walgreens Boots Alliance
- Most Powerful Women 2022 - Breaking Barriers;17:23Conferences, MPW Summit;
- There are only 44 women and 6 Black CEOs leading Fortune 500 companies;2:16Series, Magazine Videos;
- Most Powerful Women 2021: Rosalind Brewer ;1:26Digital Features;
- Walgreens President weighs in on COVID-19 testing and eventual vaccine;6:07Series, On Leading;
